By Counterforce Health Team in Xembify (immune globulin, SC) —

Complete Guide to Getting Xembify (Immune Globulin, SC) Covered by Aetna CVS Health in Illinois: Forms, Appeals, and Timeline

Answer Box: Getting Xembify Covered by Aetna CVS Health in Illinois

Xembify (immune globulin, SC) requires prior authorization from Aetna CVS Health in Illinois. The fastest path to approval: (1) Submit complete PA request via Availity Provider Portal with primary immunodeficiency diagnosis, lab values showing low IgG levels, and infection history; (2) Include documentation of any failed IVIG/SCIG trials if step therapy applies; (3) If denied, file internal appeal within 180 days, then external review within 4 months under Illinois law. Start today: Verify your plan's formulary status and gather clinical records showing recurrent infections and immunoglobulin deficiency.

Table of Contents

  1. Who Should Use This Guide
  2. Member & Plan Basics
  3. Clinical Criteria for Approval
  4. Required Documentation
  5. Submission Process
  6. Specialty Pharmacy Requirements
  7. After Submission: What to Expect
  8. Appeals Process in Illinois
  9. Common Denial Reasons & How to Fix Them
  10. Quick Reference Checklist
  11. FAQ

Who Should Use This Guide

This guide helps patients with primary immunodeficiency (PID) and their healthcare providers navigate Aetna CVS Health's prior authorization process for Xembify in Illinois. You'll need this if:

  • Your doctor prescribed Xembify for primary immunodeficiency
  • You have Aetna insurance through CVS Health
  • You live in Illinois or have Illinois-regulated coverage
  • You've received a denial letter and need to appeal

Expected outcome: With complete documentation, initial approvals typically take 30-45 days. Appeals can extend this timeline, but Illinois law provides strong external review rights that often reverse inappropriate denials.

Member & Plan Basics

Coverage Requirements

Active Coverage: Verify your Aetna plan is active and includes prescription drug benefits. Most Aetna plans require prior authorization for specialty medications like Xembify.

Plan Types: Commercial, Medicare Advantage, and Medicaid managed care plans all require PA. Check your specific plan's formulary as Xembify may be preferred or non-preferred depending on your coverage.

Deductibles: High-deductible plans may require meeting your annual deductible before coverage begins. Specialty tier copays typically range from $50-$500+ per month.

Note: CVS Caremark manages most Aetna specialty pharmacy benefits. Confirm your plan routes through CVS Specialty Pharmacy for optimal coverage.

Clinical Criteria for Approval

Primary Indication

Xembify is FDA-approved for primary humoral immunodeficiency (PID) in patients aged 2 years and older. Aetna considers other uses experimental without clinical evidence.

Laboratory Requirements

Documentation must include:

  • IgG levels more than 2 standard deviations below age-adjusted reference range
  • IgA and/or IgM deficiency (depending on specific PID type)
  • Impaired vaccine response despite previous immunizations
  • Exclusion of secondary causes (HIV, malignancy, drug-induced immunosuppression)

Clinical Evidence

Required infection history documentation:

  • ≥2 serious bacterial infections (sepsis, pneumonia, meningitis) within 1 year
  • ≥4 ear infections or ≥2 serious sinus infections requiring prolonged antibiotic therapy
  • Infections with unusual pathogens or poor wound healing

Step Therapy

Aetna may require trial/failure of preferred IVIG or other SCIG products before approving Xembify, unless Xembify is your plan's preferred agent. Document:

  • Previous IVIG/SCIG products tried
  • Duration of treatment
  • Reason for discontinuation (adverse effects, lack of efficacy, access issues)
  • Clinical rationale for switching to Xembify

Required Documentation

ICD-10 Diagnostic Codes

Use precise codes matching your clinical diagnosis:

  • D80.0: Hereditary hypogammaglobulinemia
  • D80.1: Common variable immunodeficiency (CVID)
  • D80.2: Selective IgA deficiency
  • D80.3: Selective IgG subclass deficiency
  • D80.6: Antibody deficiency with near-normal immunoglobulins

Billing Codes

  • HCPCS: J1558 (Injection, immune globulin [Xembify], 100 mg)
  • NDC Numbers: 13533-0810-05 (1g), 13533-0810-10 (2g), 13533-0810-20 (4g), 13533-0810-50 (10g)

Medical Necessity Letter Components

Your provider's letter should include:

  1. Patient demographics and insurance information
  2. Specific PID diagnosis with ICD-10 code
  3. Clinical presentation (infection history, symptoms)
  4. Laboratory results (immunoglobulin levels, vaccine titers)
  5. Prior treatments attempted and outcomes
  6. Rationale for Xembify specifically
  7. Proposed dosing and monitoring plan
  8. Provider credentials and contact information

Supporting Documents

Attach complete copies of:

  • Recent lab results (IgG, IgA, IgM levels)
  • Vaccine titer results
  • Infection history records
  • Prior IVIG/SCIG treatment records
  • Hospital discharge summaries for serious infections
  • Specialist consultation notes (immunology/allergy)

Submission Process

Electronic Submission (Preferred)

  1. Register at Availity Provider Portal
  2. Complete the prior authorization request form
  3. Upload all supporting documentation
  4. Submit and record confirmation number

Alternative Methods

Timeline

  • Standard review: 30-45 days for decision
  • Expedited review: 72 hours for urgent medical needs
  • Start early: Submit requests 60-75 days before current therapy expires
Tip: Incomplete submissions are the #1 cause of delays. Double-check all required fields and attachments before submitting.

Specialty Pharmacy Requirements

CVS Caremark Specialty

Most Aetna plans require specialty medications through CVS Caremark Specialty Pharmacy. Benefits include:

  • Coordination with your healthcare team
  • Home delivery or clinic shipment
  • Clinical support and monitoring
  • Prior authorization assistance

Transfer Process

If switching from another specialty pharmacy:

  1. Contact CVS Caremark at 1-800-237-2767
  2. Provide current prescription information
  3. Coordinate with your provider for any needed updates
  4. Verify insurance benefits and copay assistance

After Submission: What to Expect

Confirmation

  • Record your confirmation number
  • Check status via Availity portal or by calling member services
  • Respond promptly to requests for additional information

Decision Timeline

  • Approval: Typically includes 6-month initial authorization, 12-month renewals
  • Denial: Includes specific reasons and appeal rights information
  • Pended: Additional information requested; respond within 14 days to avoid automatic denial

Appeals Process in Illinois

Illinois provides robust appeal rights under the Health Carrier External Review Act. Here's your roadmap:

Internal Appeal (First Level)

  • Deadline: File within 180 days of denial
  • Process: Submit via Availity portal or written request
  • Timeline: Aetna must decide within 30 days (72 hours for expedited)
  • Include: Additional clinical evidence, peer-reviewed studies, specialist letters

External Review (Independent)

If internal appeal is denied:

  • Automatic process: Under new 2025 Illinois law, external review is automatic unless you opt out
  • Deadline: Request within 4 months of final internal denial
  • Reviewer: Board-certified specialist in immunology/relevant field
  • Timeline: Decision within 5 business days of receiving records
  • Binding: Aetna must cover if IRO approves
  • Cost: Free to patients

Illinois Resources

  • Department of Insurance: File external review
  • Attorney General Health Care Helpline: 1-877-305-5145
  • Consumer assistance: 877-527-9431

Common Denial Reasons & How to Fix Them

Denial Reason How to Overturn
Missing PID diagnosis Submit complete immunology workup with ICD-10 codes, lab values, and infection history
Step therapy not completed Document prior IVIG/SCIG trials, failures, or contraindications with clinical notes
Insufficient medical necessity Provide detailed infection history, hospitalizations, quality of life impact
Non-formulary status Request formulary exception with clinical rationale and peer-reviewed literature
Experimental/investigational Cite FDA approval, clinical guidelines, and peer-reviewed efficacy studies

Counterforce Health Support

Counterforce Health specializes in turning insurance denials into successful appeals by analyzing denial letters, identifying specific payer criteria, and drafting evidence-backed rebuttals. Their platform helps patients, clinicians, and specialty pharmacies navigate complex prior authorization requirements with payer-specific workflows and clinical documentation support.

Quick Reference Checklist

Before You Start:

  • Verify active Aetna coverage with prescription benefits
  • Confirm PID diagnosis with ICD-10 code
  • Gather immunoglobulin lab results (IgG, IgA, IgM)
  • Document infection history and hospitalizations
  • Record prior IVIG/SCIG treatments and outcomes

Documentation Packet:

  • Completed PA form with all required fields
  • Provider letter of medical necessity
  • Lab results showing immunoglobulin deficiency
  • Infection history and treatment records
  • Prior therapy documentation (if step therapy applies)
  • Specialist consultation notes

Submission:

  • Submit via Availity portal (preferred)
  • Record confirmation number
  • Set calendar reminder to check status in 2 weeks
  • Respond promptly to requests for additional information

If Denied:

  • File internal appeal within 180 days
  • Include additional clinical evidence
  • Request external review if internal appeal denied
  • Contact Counterforce Health for appeal assistance

FAQ

Q: How long does Aetna prior authorization take for Xembify in Illinois? A: Standard decisions take 30-45 days. Expedited reviews for urgent medical needs are completed within 72 hours.

Q: What if Xembify is non-formulary on my plan? A: Request a formulary exception by providing clinical rationale for why Xembify is medically necessary compared to formulary alternatives.

Q: Can I request an expedited appeal in Illinois? A: Yes, if delays would seriously jeopardize your health. Both internal appeals and external reviews can be expedited, with decisions in 24-72 hours.

Q: Does step therapy apply if I've failed therapies outside Illinois? A: Yes, document all prior treatments regardless of where they occurred. Include medical records, dosing, duration, and reasons for discontinuation.

Q: What happens if my external review is approved? A: Aetna must authorize coverage as decided by the Independent Review Organization. The decision is binding and legally enforceable.

Q: Are there cost assistance programs for Xembify? A: Yes, Grifols offers patient assistance programs. Contact them directly or check with CVS Caremark Specialty about available support options.

Q: How do I know if CVS Caremark Specialty is required? A: Check your plan documents or call member services. Most Aetna specialty medications must be filled through CVS Caremark Specialty Pharmacy.

Q: What if I need Xembify while traveling? A: Contact CVS Caremark Specialty to arrange shipment to your temporary location or coordinate with local infusion centers for administration.

Disclaimer: This guide provides general information about insurance coverage processes and should not be considered medical advice. Coverage decisions depend on individual circumstances, specific plan benefits, and clinical factors. Always consult your healthcare provider about treatment decisions and verify current coverage details with Aetna member services.

Sources & Further Reading:

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.